Stockreport

BioCryst stock rallies on start of coronavirus drug study [MarketWatch]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF BioCryst Pharmaceuticals Inc. shares rallied in the extended session Thursday after the drug maker said it was starting a clinical trial to test its COVID-19 treatment. [Read more]